Brief: Meilleure Health International Industry Says Unit To Buy Stake In Yunnan Hansu Biotechnology
14/02/2018 13:22
Feb 14 (Reuters) - Meilleure Health International Industry
Group Ltd 2327.HK :
* WUHU MEILLEURE TO BUY 20% EQUITY INTEREST OF YUNNAN HANSU
BIOTECHNOLOGY FOR RMB60 MILLION FROM HEMP INVESTMENT
* APPLICATION MADE TO STOCK EXCHANGE FOR RESUMPTION OF
TRADING IN
SHARES WITH EFFECT FROM 15 FEB
Source text for Eikon: ID:nHKS2bTRKY
Further company coverage: 2327.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Meilleure Health International Industry
See all newsBrief: Meilleure Health International Industry To Buy Tech-Medi Development For HK$35.2 Mln
Hong Kong's Meilleure Health H1 revenue surges on property sales, but margins hit
Brief: Meilleure Health International Industry Expects HY Profit Attributable Of At Least HK$27 MLN
Brief: Meilleure Health International Industry To Buy Jiangsu Yide For RMB124.8 Million
Brief: Meilleure Health International Industry Expects Profit Of Hk$14-16 Million For H1 2025